| Name | Title | Contact Details |
|---|
Cardinal Health, Inc. (NYSE: CAH), a global health services and products company, brings scaled solutions that help our customers thrive in a changing world. We improve the cost-effectiveness of healthcare through solutions that improve the efficiency of the supply chain; optimize the process and performance of healthcare; provide clinically proven, daily use medical products and pharmaceuticals; and connect patients, providers, payers, pharmacists and manufacturers for seamless care coordination and better patient management. Backed by nearly 100 years of experience, we rank among the top 50 on the Fortune 500 and among the Fortune Global 100. We support our partners with more than 37,000 employees in nearly 60 countries worldwide.
Medical Technologies is a Burnsville, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
About HealthTrust HealthTrust Purchasing Group is a healthcare group purchasing organization
Clarity Medical Systems, Inc. is a medical device company that develops, manufactures and markets integrated optical systems and services to enhance the clinician`s ability to diagnose, manage, and treat eye disorders. These patented devices combine innovative 21st century optical, electronic and information technologies that change the very nature of eye healthcare. The Company`s initial product line has improved the standard of eye healthcare for pediatrics and is sold to leading Neonatal Intensive Care Units on a global basis. The Company`s first product line, the RetCam, is a major achievement in providing miniaturized, integrated, wide-field imaging for management of eye disorders in infants. The RetCam has revolutionized disease management for pediatric eye disorders and has been the enabling tool for several international clinical trials. Customers include: Stanford University, Bascom-Palmer Eye Institute, UCLA Jules Stein Eye Institute, Toronto Hospital for Sick Kids, Cleveland Clinic, USC Children`s Hospital, and Wills Eye Institute.
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.